615 filings
Page 2 of 31
8-K
p61oi auoov1
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
vqfxmsux
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
PX14A6G
0llxv77 at1
18 May 23
Letter to shareholders
4:46pm
DEFA14A
ovcmkoy27se6fzc1quh1
17 May 23
Additional proxy soliciting materials
4:04pm
8-K
v5agx rge
4 May 23
Regeneron Reports First Quarter 2023 Financial and Operating Results
7:11am
ARS
tn1577cye9k3xwtjr
21 Apr 23
Annual report to shareholders
4:09pm
DEFA14A
pfy1j ihtks25guz2pv5
21 Apr 23
Additional proxy soliciting materials
4:03pm
8-K
z6nhty7sjdl8ize5i33
17 Apr 23
Departure of Directors or Certain Officers
7:37am
8-K
s2p53gr6a
10 Apr 23
Results of Operations and Financial Condition
7:01am
8-K
brx3ulvy
29 Mar 23
Entry into a Material Definitive Agreement
4:01pm
8-K
5cj61
3 Feb 23
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
7:06am
8-K
2k0vr94e4hk uhbc3sz7
9 Jan 23
J.P. Morgan Healthcare Conference 2023 Strategy & Business Update 2 Leonard S. Schleifer, MD, PhD Co - Founder, President & Chief Executive Officer
8:49am
8-K
ntsqz9hp6mn78hf18an
20 Dec 22
Entry into a Material Definitive Agreement
4:01pm
UPLOAD
xfw lji2xv5l2hry9
7 Nov 22
Letter from SEC
12:00am
8-K
98stpzmyvqdte66w
3 Nov 22
Regeneron Reports Third Quarter 2022 Financial and Operating Results
7:19am
CORRESP
s6fjq 0k1mw
7 Oct 22
Correspondence with SEC
12:00am